One-Time CRISPR Therapy Cuts ‘Bad’ Cholesterol by 52% With Effects Lasting a Full Year
A single infusion of an experimental gene-editing therapy cut “bad” LDL cholesterol by 52 percent, with the benefit still holding a full year after treatment — an early sign...
